|
Alison Freeman-Gleason served as partner of the Firm until 2011. She specializes in intellectual property transactions and complex commercial contracting, with particular expertise in cross-border licensing, distribution, development and commercialization collaborations, manufacturing, supply, services and other corporate partnering agreements. During her more than 20 years of practice, Ms. Freeman-Gleason has counseled a wide variety of companies, including biotechnology, medical device, specialty pharmaceutical, global health, clean technology and advanced materials companies, and has assisted them in achieving their strategic business objectives through structuring, negotiating and drafting agreements to develop, commercialize and monetize their intellectual property and other assets.
Ms. Freeman-Gleason's clients range from startups to large public companies and her practice ranges from early-stage university/institute licensing and material transfer agreements, to global co-development, co-promotion and other strategic collaborations, to intellectual property and other asset acquisitions and spin-outs. Her global collaboration transactions have included deals between Bayer Healthcare and Regeneron, Otsuka Pharmaceutical and Bristol-Myers Squibb, Bayer Schering Pharma and ZymoGenetics, Otsuka Pharmaceutical and UCB Pharma, Bayer Healthcare and Nuvelo (winner of the Allicense Breakthrough Alliance Award), and a variety of agreements representing the global health nonprofit organization, PATH. Much of Ms. Freeman-Gleason's practice involves international transactions and she has traveled frequently to Asia and Europe for negotiations. She is also a speaker at conferences on corporate partnering and technology licensing.
Prior to joining the Firm, Ms. Freeman-Gleason was a shareholder at Heller Ehrman LLP, where she served as Co-Chair of that firm's Energy & Clean Technologies practice group. As such, her practice included project development, technology transfer, joint ventures and mergers & acquisitions in the energy technologies and advanced materials areas. While at Heller Ehrman, Ms. Freeman-Gleason co-authored " How to Turn Clean Energy into a Powerhouse , " Business Week, September 5, 2007. In addition to her law background, Ms. Freeman-Gleason gained invaluable experience as a founder of the successful green building materials company, ecohaus.
Ms. Freeman-Gleason earned her J.D. from Yale Law School, where she was Note Editor for the Yale Law & Policy Review. She graduated with a B.A. and an M.A., magna cum laude, from Emory University, where she was elected Phi Beta Kappa. She was also a law clerk to the Honorable Robert H. Hall of the United States District Court for the Northern District of Georgia.
Ms. Freeman-Gleason is a volunteer for the Washington Attorneys Assisting Community Organizations (WAACO) and other charitable organizations. She is admitted to practice law in Washington and Connecticut and is a member of the Washington State Bar Association.
Education- Yale Law School
JD - Emory University
MA, magna cum laude - Emory University
MA, magna cum laude, Phi Beta Kappa
Admissions
Memberships
- Washington Biotechnology and Biomedical Association
- Washington State Bar Association
|